BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh KP, Crane M, Audsley J, Avihingsanon A, Sasadeusz J, Lewin SR. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS 2017;31:2035-52. [PMID: 28692539 DOI: 10.1097/QAD.0000000000001574] [Cited by in Crossref: 124] [Cited by in F6Publishing: 134] [Article Influence: 24.8] [Reference Citation Analysis]
Number Citing Articles
1 Ihongbe JC, Enitan SS, Dada MO, Effiong EJ, Kemiki O. Detection of Hepatitis B Virus Serological markers among Adult HIV Positive Female Patients on HAART in Ogun State, Nigeria.. [DOI: 10.32388/ylb5k9] [Reference Citation Analysis]
2 Moochani SS, Moghoofei M, Tavakoli A, Tabibzadeh A, Ghorbani S, Ghaffari H, Mostafaei S, Monavari SH, Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, Department of Microbiology, Faculty of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran, Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran, Department of Bacteriology and Virology, Semnan University of Medical Sciences, Semnan, Iran, Department of Biostatistics, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran, Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran. Evaluation of miRNA-122, miRNA-149, miRNA-199a, and miRNA- let7 Expression in HIV, HBV, and HIV-HBV Co-infected Patients. Iran J Med Microbiol 2022;16:420-429. [DOI: 10.30699/ijmm.16.5.420] [Reference Citation Analysis]
3 Musafili N, Hadisaputro S, Sofro MAU, Sutiningsih D. Influence of Epidemiological Risk Factors for Occurrence of Hepatitis B Virus (HBV) Co-Infection in HIV/AIDS Patients: (Study in dr. Kariadi Hospital, Semarang, Indonesia). Comm Health Epid J 2022;7:545-552. [DOI: 10.14710/jekk.v7i2.13714] [Reference Citation Analysis]
4 Liu W, Yu S, Yan B. Effect of alcohol exposure on the efficacy and safety of tenofovir alafenamide fumarate, a major medicine against human immunodeficiency virus. Biochem Pharmacol 2022;204:115224. [PMID: 36007574 DOI: 10.1016/j.bcp.2022.115224] [Reference Citation Analysis]
5 Wang XQ, Zerbato JM, Avihingsanon A, Fisher K, Schlub T, Rhodes A, Audsley J, Singh KP, Zhao W, Lewin SR, Palmer S. Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals. J Virol 2022;:e0058822. [PMID: 35916523 DOI: 10.1128/jvi.00588-22] [Reference Citation Analysis]
6 Wang X, Liu J, Wang Q, Qiao Y, Jin X, Li Z, Yan W, Du M, Jing W, Wang A, Liu M. Economic-related inequalities in hepatitis B virus infection among 115.8 million pregnant women in China from 2013 to 2020. eClinicalMedicine 2022;49:101465. [DOI: 10.1016/j.eclinm.2022.101465] [Reference Citation Analysis]
7 Hawkins C, Kang M, Bhattacharya D, Cloherty G, Kuhns M, Matining R, Thio C, Samaneka W, Chinula L, Mulinda N, Badal-Faesen S, Sugandhavesa P, Lama J, Gaseitsiwe S, Holzmayer V, Anderson M, Murphy R, Peters M. Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy. AIDS 2022;36:975-84. [PMID: 35165216 DOI: 10.1097/QAD.0000000000003193] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Endashaw EE, Mekonnen TT, Werner F. Modeling the Effect of Vaccination and Treatment on the Transmission Dynamics of Hepatitis B Virus and HIV/AIDS Coinfection. Journal of Applied Mathematics 2022;2022:1-27. [DOI: 10.1155/2022/5246762] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alisjahbana B, Sulastri N, Livia R, Apriani L, Verrall AJ, Sahiratmadja E. Neutrophils and lymphocytes in relation to MMP-8 and MMP-9 levels in pulmonary tuberculosis and HIV co-infection. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 2022;27:100308. [DOI: 10.1016/j.jctube.2022.100308] [Reference Citation Analysis]
10 Sultana C, Casian M, Oprea C, Ianache I, Grancea C, Chiriac D, Ruta S. Hepatitis B Virus Genotypes and Antiviral Resistance Mutations in Romanian HIV-HBV Co-Infected Patients. Medicina 2022;58:531. [DOI: 10.3390/medicina58040531] [Reference Citation Analysis]
11 Msomi N, Parboosing R, Wilkinson E, Giandhari J, Govender K, Chimukangara B, Mlisana KP. Persistent Hepatitis B Viraemia with Polymerase Mutations among HIV/HBV Co-Infected Patients on HBV-Active ART in KwaZulu-Natal, South Africa. Viruses 2022;14:788. [DOI: 10.3390/v14040788] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Seyoum E, Demissie M, Worku A, Mihret A, Abdissa A, Berhane Y. Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study. BMC Public Health 2022;22:644. [PMID: 35379215 DOI: 10.1186/s12889-022-13025-y] [Reference Citation Analysis]
13 Zaongo SD, Ouyang J, Chen Y, Jiao Y, Wu H, Chen Y. HIV Infection Predisposes to Increased Chances of HBV Infection: Current Understanding of the Mechanisms Favoring HBV Infection at Each Clinical Stage of HIV Infection. Front Immunol 2022;13:853346. [DOI: 10.3389/fimmu.2022.853346] [Reference Citation Analysis]
14 Araujo NM, Osiowy C. Hepatitis B Virus Genotype G: The Odd Cousin of the Family. Front Microbiol 2022;13:872766. [DOI: 10.3389/fmicb.2022.872766] [Reference Citation Analysis]
15 Lee TH, Hunt CM, Maier MM, Lowy E, Beste LA. Hepatitis B Virus-Related Care Quality In Patients With Hepatitis B/Hiv Coinfection Versus Hepatitis B Monoinfection: A National Cohort Study. Clin Infect Dis 2022:ciac227. [PMID: 35349635 DOI: 10.1093/cid/ciac227] [Reference Citation Analysis]
16 Belyhun Y, Liebert UG, Maier M. Molecular epidemiology of hepatitis B virus among HIV co-infected and mono-infected cohorts in Northwest Ethiopia. Virol J 2022;19:53. [PMID: 35331278 DOI: 10.1186/s12985-022-01774-6] [Reference Citation Analysis]
17 Liu X, Lin L, Lu L, Li X, Han Y, Qiu Z, Li X, Li Y, Song X, Cao W, Li T. Comparative Transcriptional Analysis Identified Characteristic Genes and Patterns in HIV-Infected Immunological Non-Responders. Front Immunol 2022;13:807890. [PMID: 35154126 DOI: 10.3389/fimmu.2022.807890] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Iacob SA, Iacob DG. Non-Alcoholic Fatty Liver Disease in HIV/HBV Patients – a Metabolic Imbalance Aggravated by Antiretroviral Therapy and Perpetuated by the Hepatokine/Adipokine Axis Breakdown. Front Endocrinol 2022;13:814209. [DOI: 10.3389/fendo.2022.814209] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Chen S, Ren F, Xu L, Gao Y, Zhang X, Tian Y, Fan Z, Cao Y, Huang X, Liu M. Underestimated prevalence of HIV/HBV/HDV triple infection globally: a systematic review and meta-analysis (Preprint). JMIR Public Health and Surveillance 2022. [DOI: 10.2196/37016] [Reference Citation Analysis]
20 Wan Q, Anugwom C, Desalegn H, Debes JD. Hepatocellular carcinoma in Hepatitis B and Human Immunodeficiency Virus coinfection in Africa: a focus on surveillance. Hepatoma Res 2022;8:39. [PMID: 36277115 DOI: 10.20517/2394-5079.2022.32] [Reference Citation Analysis]
21 Reeves I, Cromarty B, Deayton J, Dhairyawan R, Kidd M, Taylor C, Thornhill J, Tickell-Painter M, van Halsema C. British HIV Association guidelines for the management of HIV-2 2021. HIV Med 2021;22 Suppl 4:1-29. [PMID: 34927347 DOI: 10.1111/hiv.13204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bekele Y, Berzofsky JA, Chiodi F. Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals. Vaccines (Basel) 2021;9:1484. [PMID: 34960230 DOI: 10.3390/vaccines9121484] [Reference Citation Analysis]
23 Mocroft A, Miro JM, Wandeler G, Llibre JM, Boyd A, van Bremen K, Beniowski M, Mikhalik J, Cavassini M, Maltez F, Duvivier C, Uberti Foppa C, Knysz B, Bakowska E, Kuzovatova E, Domingo P, Zagalo A, Viard JP, Degen O, Milinkovic A, Benfield T, Peters L; EuroSIDA study group. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. HIV Med 2021. [PMID: 34889022 DOI: 10.1111/hiv.13210] [Reference Citation Analysis]
24 Rivera AS, Machenry S, Okpokwu J, Olatunde B, Ugoagwu P, Auwal M, Sule H, Agaba P, Agbaji OO, Thio CL, Murphy RL, Hawkins C. HBV co-infection is associated with persistently elevated liver stiffness measurement in HIV-positive adults: A 6-year single-centre cohort study in Nigeria. Antiviral Therapy 2021;26:106-16. [DOI: 10.1177/13596535211058262] [Reference Citation Analysis]
25 Kulkarni AV, Duvvuru NR. Management of hepatitis B and C in special population. World J Gastroenterol 2021; 27(40): 6861-6873 [PMID: 34790011 DOI: 10.3748/wjg.v27.i40.6861] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
26 Khalili M, King WC, Kleiner DE, Chung RT, Bhan AK, Ghany MG, Sulkowski MS, Lisker-Melman M, Jain MK, Janssen HLA, Hinerman AS, Sanyal AJ, Sterling RK. Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. Clin Infect Dis 2021:ciab764. [PMID: 34698347 DOI: 10.1093/cid/ciab764] [Reference Citation Analysis]
27 Cheng Z, Lin P, Cheng N. HBV/HIV Coinfection: Impact on the Development and Clinical Treatment of Liver Diseases. Front Med (Lausanne) 2021;8:713981. [PMID: 34676223 DOI: 10.3389/fmed.2021.713981] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
28 Kouamé GM, Gabillard D, Moh R, Badje A, Ntakpé JB, Emième A, Maylin S, Toni TD, Ménan H, Zoulim F, Danel C, Anglaret X, Eholié S, Lacombe K, Boyd A. Higher risk of mortality in HIV-HBV co-infected patients from sub-Saharan Africa is observed at lower CD4 + cell counts. Antiviral Therapy 2021;26:25-33. [DOI: 10.1177/13596535211039589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Masroor H, Qazi UM, Masroor A, Saleem A, Khalil G, Abbas K. Coinfection of Hepatitis B and Hepatitis C Virus in Patients With Human Immunodeficiency Virus. Cureus 2021;13:e16474. [PMID: 34466302 DOI: 10.7759/cureus.16474] [Reference Citation Analysis]
30 Lima LJD, Oliveira ALLD, Nascimento VA, Werle JE, Santos PGSD, M. Piasentini L, Borges LADC, Martins ADA, Tognini MDO, Lemos MSCD, Tair RS, Britto JALD. Hiv And Hepatitis B Virus Co-Infection. Int J Innov Educ Res 2021;9:99-109. [DOI: 10.31686/ijier.vol9.iss9.3319] [Reference Citation Analysis]
31 Sterling RK, King WC, Khalili M, Chung RT, Sulkowski M, Jain MK, Lisker-Melman M, Ghany MG, Wong DK, Hinerman AS, Bhan AK, Wahed AS, Kleiner DE; HBV-HIV Cohort Study of the Hepatitis B Research Network. A Prospective Study Evaluating Changes in Histology, Clinical and Virologic Outcomes in HBV-HIV Co-infected Adults in North America. Hepatology 2021;74:1174-89. [PMID: 33743541 DOI: 10.1002/hep.31823] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
32 Mican R, Busca Arenzana C, Vasquez J, Daroca G, Perez-Valero I, Martin-Carbonero L. Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status. AIDS 2021;35:1707-8. [PMID: 34270493 DOI: 10.1097/QAD.0000000000002941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Pérez-Latorre L, Berenguer J, Micán R, Montero M, Cifuentes C, Puig T, Sanz J, Ferrero OL, De La Fuente B, Rodríguez C, Reus S, Hernández-Quero J, Gaspar G, Pérez-Martínez L, García C, Force L, Veloso S, De Miguel M, Jarrín I, González-García J; GeSIDA 8514 Study Group. HIV/HBV coinfection: temporal trends and patient characteristics, Spain, 2002 to 2018. Euro Surveill 2021;26. [PMID: 34169818 DOI: 10.2807/1560-7917.ES.2021.26.25.2000236] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
34 Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-gagnon M, Hogg R, Cooper CL. Clinical and demographic predictors of antiretroviral efficacy in HIV–HBV co-infected patients. Official Journal of the Association of Medical Microbiology and Infectious Disease Canada 2021;6:137-148. [DOI: 10.3138/jammi-2020-0011] [Reference Citation Analysis]
35 Somé EN, Guingané AN, Zongo I, Sané D, Drabo KM, Sombié R. Chronic viral HBeAg-negative hepatitis B: Epidemiological, clinical and biochemical characteristics in an outpatient descriptive cohort in Burkina Faso. Clinical Epidemiology and Global Health 2021;11:100799. [DOI: 10.1016/j.cegh.2021.100799] [Reference Citation Analysis]
36 Mukhatayeva A, Mustafa A, Dzissyuk N, Issanov A, Bayserkin B, Vermund SH, Ali S. Hepatitis B, Hepatitis C, tuberculosis and sexually-transmitted infections among HIV positive patients in Kazakhstan. Sci Rep 2021;11:13542. [PMID: 34188081 DOI: 10.1038/s41598-021-92688-w] [Reference Citation Analysis]
37 Kwofie TB, Adigbli D, Osei-Yeboah J, Ativi E, Lokpo SY. Hepatitis B and C infections in HIV-1 patients on combination antiretroviral therapy (cART) in Ghana: implications for immunologic recovery, clinical response to treatment, and hepatotoxicity. Heliyon 2021;7:e07172. [PMID: 34141932 DOI: 10.1016/j.heliyon.2021.e07172] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Weldemhret L. Epidemiology and Challenges of HBV/HIV Co-Infection Amongst HIV-Infected Patients in Endemic Areas: Review. HIV AIDS (Auckl) 2021;13:485-90. [PMID: 33981165 DOI: 10.2147/HIV.S273649] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
39 Liu Y, Maya S, Ploss A. Animal Models of Hepatitis B Virus Infection-Success, Challenges, and Future Directions. Viruses 2021;13:777. [PMID: 33924793 DOI: 10.3390/v13050777] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 13.0] [Reference Citation Analysis]
40 Dezanet LNC, Kassime R, Miailhes P, Lascoux-combe C, Chas J, Maylin S, Gabassi A, Rougier H, Delaugerre C, Lacombe K, Boyd A. Effect of viral replication and liver fibrosis on all-cause mortality in HIV/HBV coinfected patients: a retrospective analysis of a 15-year longitudinal cohort.. [DOI: 10.1101/2021.04.13.21255432] [Reference Citation Analysis]
41 Boyd A, Dezanet LNC, Kassime R, Miailhes P, Lascoux-Combe C, Chas J, Girard PM, Gozlan J, Zoulim F, Delaugerre C, Rougier H, Lacombe K. Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort Study. JMIR Res Protoc 2021;10:e24731. [PMID: 33821807 DOI: 10.2196/24731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
42 Jose-Abrego A, Roman S, Rebello Pinho JR, de Castro VFD, Panduro A. Hepatitis B Virus (HBV) Genotype Mixtures, Viral Load, and Liver Damage in HBV Patients Co-infected With Human Immunodeficiency Virus. Front Microbiol 2021;12:640889. [PMID: 33746932 DOI: 10.3389/fmicb.2021.640889] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
43 Malagnino V, Cerva C, Teti E, Campogiani L, Compagno M, Foroghi Biland L, Saderi L, Armenia D, Salpini R, Svicher V, Sotgiu G, Iannetta M, Andreoni M, Sarmati L. Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers. Sci Rep 2021;11:3965. [PMID: 33597631 DOI: 10.1038/s41598-021-83616-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Sun J, Althoff KN, Jing Y, Horberg MA, Buchacz K, Gill MJ, Justice AC, Rabkin CS, Goedert JJ, Sigel K, Cachay E, Park L, Lim JK, Kim HN, Lo Re V 3rd, Moore R, Sterling T, Peters MG, Achenbach CJ, Silverberg M, Thorne JE, Mayor AM, Crane HM, Kitahata MM, Klein M, Kirk GD; North American AIDS Cohort Collaboration on Research and Design of IeDEA. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015. JAMA Netw Open 2021;4:e2037512. [PMID: 33595662 DOI: 10.1001/jamanetworkopen.2020.37512] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
45 Seremba E, Ocama P, Ssekitoleko R, Mayanja-Kizza H, Adams SV, Orem J, Katabira E, Reynolds SJ, Nabatanzi R, Casper C, Phipps W. Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda. Vaccine 2021;39:1265-71. [PMID: 33516601 DOI: 10.1016/j.vaccine.2021.01.043] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Mohareb AM, Kouamé GM, Gabassi A, Gabillard D, Moh R, Badje A, Emième A, Maylin S, Ménan H, Hyle EP, Delaugerre C, Danel C, Anglaret X, Lacombe K, Eholié SP, Boyd A. Mortality in relation to hepatitis B virus (HBV) infection status among HIV-HBV co-infected patients in sub-Saharan Africa after immediate initiation of antiretroviral therapy. J Viral Hepat 2021;28:621-9. [PMID: 33382189 DOI: 10.1111/jvh.13461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Al-Mozaini M, Alrahbeni T, Dirar Q, Alotibi J, Alrajhi A. HIV in the Kingdom of Saudi Arabia: Can We Change the Way We Deal with Co-Infections. Infect Drug Resist 2021;14:111-7. [PMID: 33500633 DOI: 10.2147/IDR.S270355] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
48 Opaleye OO, Akanbi OA, Osundare FA, Wang B, Adesina O, Oluremi AS, Sunday ST, Akindele AA, Klink P, Bock CT. Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria. Virol J 2021;18:20. [PMID: 33446224 DOI: 10.1186/s12985-021-01493-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Wei F, da Silva-júnior EF, Liu X, Zhan P. HIV-1 and HBV RNase H as Metal-Chelating Inhibitors: Discovery and Medicinal Chemistry Strategies. Human Viruses: Diseases, Treatments and Vaccines 2021. [DOI: 10.1007/978-3-030-71165-8_28] [Reference Citation Analysis]
50 Tung BT, Nhung NH, Hang TTT, Linh VK. Herbal Medicine and Its Bioactive Compounds for Treatment of Hepatitis B. Advances in Medical Diagnosis, Treatment, and Care 2021. [DOI: 10.4018/978-1-7998-4453-2.ch008] [Reference Citation Analysis]
51 Amponsah-Dacosta E, Tamandjou Tchuem C, Anderson M. Chronic hepatitis B-associated liver disease in the context of human immunodeficiency virus co-infection and underlying metabolic syndrome. World J Virol 2020; 9(5): 54-66 [PMID: 33362998 DOI: 10.5501/wjv.v9.i5.54] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Patel NH, Meier-Stephenson V, Genetu M, Damtie D, Abate E, Alemu S, Aleka Y, Van Marle G, Fonseca K, Coffin CS, Deressa T. Prevalence and genetic variability of occult hepatitis B virus in a human immunodeficiency virus positive patient cohort in Gondar, Ethiopia. PLoS One 2020;15:e0242577. [PMID: 33211768 DOI: 10.1371/journal.pone.0242577] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
53 Salpini R, Malagnino V, Piermatteo L, Mulas T, Alkhatib M, Scutari R, Teti E, Cerva C, Yu La Rosa K, Brugneti M, Bertoli A, Rossi B, Holzmayer V, Gersch J, Kuhns M, Cloherty G, Ceccherini-Silberstein F, Perno CF, Iannetta M, Andreoni M, Sarmati L, Svicher V. Cryptic HBV Replicative Activity Is Frequently Revealed in Anti-HBc-Positive/HBsAg-Negative Patients with HIV Infection by Highly Sensitive Molecular Assays, and Can Be Predicted by Integrating Classical and Novel Serological HBV Markers. Microorganisms 2020;8:E1819. [PMID: 33218205 DOI: 10.3390/microorganisms8111819] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
54 Malagnino V, Cerva C, Cingolani A, Ceccherini-Silberstein F, Vergori A, Cuomo G, Perno CF, Puoti M, d'Arminio Monforte A, Cozzi-Lepri A, Andreoni M, Sarmati L; ICONA Foundation Study Group . HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients. Open Forum Infect Dis 2021;8:ofaa566. [PMID: 33447635 DOI: 10.1093/ofid/ofaa566] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Sun S, Yang Q, Sheng Y, Fu Y, Sun C, Deng C. Investigational drugs with dual activity against HBV and HIV (Review). Exp Ther Med 2021;21:35. [PMID: 33262821 DOI: 10.3892/etm.2020.9467] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Rodríguez M, Buti M, Esteban R, Lens S, Prieto M, Suárez E, García-samaniego J. Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020). Gastroenterología y Hepatología (English Edition) 2020;43:559-587. [DOI: 10.1016/j.gastre.2020.03.008] [Reference Citation Analysis]
57 Dezanet LNC, Maylin S, Gabassi A, Rougier H, Miailhes P, Lascoux-Combe C, Chas J, Girard PM, Delaugerre C, Zoulim F, Lacombe K, Boyd A. Correlation of serum hepatitis B core-related antigen with hepatitis B virus total intrahepatic DNA and covalently closed circular-DNA viral load in HIV-hepatitis B coinfection. AIDS 2020;34:1943-9. [PMID: 32773480 DOI: 10.1097/QAD.0000000000002659] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
58 Awoke N, Mulgeta H, Lolaso T, Tekalign T, Samuel S, Obsa MS, Olana R. Full-dose hepatitis B virus vaccination coverage and associated factors among health care workers in Ethiopia: A systematic review and meta-analysis. PLoS One 2020;15:e0241226. [PMID: 33108365 DOI: 10.1371/journal.pone.0241226] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
59 Xiao Y, Thompson AJ, Howell J. Point-of-Care Tests for Hepatitis B: An Overview. Cells 2020;9:E2233. [PMID: 33023265 DOI: 10.3390/cells9102233] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
60 Boyd A, Dezanet LNC, Kassime R, Miailhes P, Lascoux-combe C, Chas J, Girard P, Gozlan J, Zoulim F, Delaugerre C, Rougier H, Lacombe K. Subclinical and Clinical Outcomes in Patients Coinfected With HIV and Chronic Hepatitis B Virus From Clinical Outpatient Centers in France: Protocol for an Ambispective, Longitudinal Cohort Study (Preprint).. [DOI: 10.2196/preprints.24731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Santos ME, Protopopescu C, Ribero RA, Benzaken AS, Pereira GFM, Stevens A, Nishimwe ML, Yaya I, Carrieri P, Araújo WN. Population attributable fractions of mortality in people living with HIV: roles of delayed antiretroviral therapy, hepatitis coinfections and social factors. AIDS 2020;34:1843-54. [PMID: 32889854 DOI: 10.1097/QAD.0000000000002621] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
62 Chihota BV, Wandeler G, Chilengi R, Mulenga L, Chung RT, Bhattacharya D, Egger M, Vinikoor MJ. High Rates of Hepatitis B Virus (HBV) Functional Cure Among Human Immunodeficiency Virus-HBV Coinfected Patients on Antiretroviral Therapy in Zambia. J Infect Dis 2020;221:218-22. [PMID: 31613956 DOI: 10.1093/infdis/jiz450] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
63 Goverwa-Sibanda TP, Mupanguri C, Timire C, Harries AD, Ngwenya S, Chikwati E, Mapfuma C, Mushambi F, Tweya H, Ndlovu M. Hepatitis B infection in people living with HIV who initiate antiretroviral therapy in Zimbabwe. Public Health Action 2020;10:97-103. [PMID: 33134123 DOI: 10.5588/pha.20.0008] [Reference Citation Analysis]
64 Adeyemi OA, Itanyi IU, Ozigbu CE, Stadnick N, Tsuyuki K, Olayiwola O, Ogidi AG, Eze C, Aarons GA, Onoka CA, Ezeanolue EE. Sero-prevalence and determinants of Hepatitis B among a cohort of HIV-infected women of reproductive age in Nigeria. PLoS One 2020;15:e0236456. [PMID: 32941424 DOI: 10.1371/journal.pone.0236456] [Reference Citation Analysis]
65 Kim HN. Chronic Hepatitis B and HIV Coinfection: A Continuing Challenge in the Era of Antiretroviral Therapy. Curr Hepatol Rep 2020;19:345-53. [PMID: 33796434 DOI: 10.1007/s11901-020-00541-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
66 Adesegun OA, Olaniran OH, Bamidele E, Inyang JN, Adegbe M, Binuyo TO, Ehioghae O, Adeyemi O, Oyebisi O, Idowu AO, Ajose O. HIV-hepatitis co-infection in a rural community in Northern Nigeria. Pan Afr Med J 2020;36:352. [PMID: 33224418 DOI: 10.11604/pamj.2020.36.352.23978] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Yu S, Yu C, Li J, Liu S, Wang H, Deng M. Hepatitis B and hepatitis C prevalence among people living with HIV/AIDS in China: a systematic review and Meta-analysis. Virol J 2020;17:127. [PMID: 32831118 DOI: 10.1186/s12985-020-01404-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
68 Pereson MJ, Martínez AP, Isaac K, Laham G, Ridruejo E, Garcia GH, Flichman DM, Di Lello FA. Prevalence of Hepatitis B, Hepatitis C and HIV infection among patients undergoing hemodialysis in Argentina.. [DOI: 10.1101/2020.08.04.20168385] [Reference Citation Analysis]
69 Stoeckle K, Johnston CD, Jannat-Khah DP, Williams SC, Ellman TM, Vogler MA, Gulick RM, Glesby MJ, Choi JJ. COVID-19 in Hospitalized Adults With HIV. Open Forum Infect Dis 2020;7:ofaa327. [PMID: 32864388 DOI: 10.1093/ofid/ofaa327] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
70 Makuza JD, Nisingizwe MP, Rwema JOT, Dushimiyimana D, Habimana DS, Umuraza S, Serumondo J, Ngwije A, Semakula M, Gupta N, Nsanzimana S, Janjua NZ. Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study. BMJ Open 2020;10:e036711. [PMID: 32660951 DOI: 10.1136/bmjopen-2019-036711] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
71 van Welzen BJ, Smit C, Boyd A, Lieveld FI, Mudrikova T, Reiss P, Brouwer AE, Hoepelman AIM, Arends JE. Decreased All-Cause and Liver-Related Mortality Risk in HIV/Hepatitis B Virus Coinfection Coinciding With the Introduction of Tenofovir-Containing Combination Antiretroviral Therapy. Open Forum Infect Dis 2020;7:ofaa226. [PMID: 32665961 DOI: 10.1093/ofid/ofaa226] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
72 Cruchet R, Dezanet LNC, Maylin S, Gabassi A, Rougier H, Miailhes P, Lascoux-Combe C, Chas J, Girard PM, Delaugerre C, Lacombe K, Boyd A. Association of Hepatitis B Core-Related Antigen and Antihepatitis B Core Antibody With Liver Fibrosis Evolution in Human Immunodeficiency Virus-Hepatitis B Virus Coinfected Patients During Treatment With Tenofovir. Open Forum Infect Dis 2020;7:ofaa215. [PMID: 33123612 DOI: 10.1093/ofid/ofaa215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
73 Archampong T, Ojewale O, Bears K, Chen Y, Lartey M, Sagoe KW, Obo-Akwa A, Gong Y, Langaee T, Kwara A. Brief Report: Relationship Between ABCC4 SNPs and Hepatitis B Virus Suppression During Tenofovir-Containing Antiretroviral Therapy in Patients With HIV/HBV Coinfection. J Acquir Immune Defic Syndr 2019;82:421-5. [PMID: 31335591 DOI: 10.1097/QAI.0000000000002136] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
74 Revill PA, Lewin SR. Editorial: Strategies and barriers for hepatitis B cure: implications for HIV. Curr Opin HIV AIDS 2020;15:151-6. [PMID: 32229770 DOI: 10.1097/COH.0000000000000620] [Reference Citation Analysis]
75 Wang W, Smith N, Makarov E, Sun Y, Gebhart CL, Ganesan M, Osna NA, Gendelman HE, Edagwa BJ, Poluektova LY. A long-acting 3TC ProTide nanoformulation suppresses HBV replication in humanized mice. Nanomedicine 2020;28:102185. [PMID: 32217146 DOI: 10.1016/j.nano.2020.102185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
76 Dehghani-dehej F, Hosseini Z, Mortazkar P, Khanaliha K, Esghaei M, Fakhim A, Bokharaei-salim F. Prevalence of HCV and/or HBV coinfection in Iranian HIV-infected patients. Future Virology 2020;15:155-63. [DOI: 10.2217/fvl-2019-0066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clin Microbiol Rev. 2020;33. [PMID: 32102898 DOI: 10.1128/cmr.00046-19] [Cited by in Crossref: 100] [Cited by in F6Publishing: 106] [Article Influence: 50.0] [Reference Citation Analysis]
78 Patel M, Waller JL, Baer SL, Spearman V, Kheda M, Young L, Nahman S, Colombo RE. Cancer incidence and risk factors in dialysis patients with human immunodeficiency virus: a cohort study. Clin Kidney J 2021;14:624-30. [PMID: 33623688 DOI: 10.1093/ckj/sfz191] [Reference Citation Analysis]
79 Weitzel T, Rodríguez F, Noriega LM, Marcotti A, Duran L, Palavecino C, Porte L, Aguilera X, Wolff M, Cortes CP. Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey. PLoS One 2020;15:e0227776. [PMID: 31917810 DOI: 10.1371/journal.pone.0227776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
80 Tserashkou DV, Gomel Regional Infectious Clinical Hospital, Gomel, the Republic of Belarus, Mitsura VM, Voropaev EV, Osipkina OV, Gomel State Medical University, Gomel, the Republic of Belarus, Gomel State Medical University, Gomel, the Republic of Belarus, Gomel State Medical University, Gomel, the Republic of Belarus. VIRAL COINFECTIONS IN PATIENTS WITH CHRONIC HEPATITIS B: THEIR PREVALENCE AND CLINICAL SIGNIFICANCE. Hepatol and Gastroenterol 2020;4:171-176. [DOI: 10.25298/2616-5546-2020-4-2-171-176] [Reference Citation Analysis]
81 Masters MC, Krueger KM, Williams JL, Morrison L, Cohn SE. Beyond one pill, once daily: current challenges of antiretroviral therapy management in the United States. Expert Rev Clin Pharmacol 2019;12:1129-43. [PMID: 31774001 DOI: 10.1080/17512433.2019.1698946] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
82 Lien K, Mayer W, Herrera R, Rosbe K, Tugizov SM. HIV-1 proteins gp120 and tat induce the epithelial-mesenchymal transition in oral and genital mucosal epithelial cells. PLoS One. 2019;14:e0226343. [PMID: 31869348 DOI: 10.1371/journal.pone.0226343] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
83 Bollinger RC, Thio CL, Sulkowski MS, McKenzie-White J, Thomas DL, Flexner C. Addressing the global burden of hepatitis B virus while developing long-acting injectables for the prevention and treatment of HIV. Lancet HIV 2020;7:e443-8. [PMID: 31870675 DOI: 10.1016/S2352-3018(19)30342-X] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
84 Ba A, Ndiaye FK, Djeng YJ, Cames C, Diack A, N'diaye O. Impact of Highly Active Antiretroviral Therapy on Chronic Hepatitis B Serological Markers among Senegalese HIV Co-infected Children. Int J MCH AIDS 2019;8:131-7. [PMID: 31824751 DOI: 10.21106/ijma.321] [Reference Citation Analysis]
85 Rana U, Driedger M, Sereda P, Pan S, Ding E, Wong A, Walmsley S, Klein M, Kelly D, Loutfy M, Thomas R, Sanche S, Kroch A, Machouf N, Roy-Gagnon MH, Hogg R, Cooper CL; Canadian Observational Cohort (CANOC) Collaboration. Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada? BMC Infect Dis 2019;19:982. [PMID: 31752729 DOI: 10.1186/s12879-019-4617-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
86 Sarmati L, Malagnino V. HBV Infection in HIV-Driven Immune Suppression. Viruses 2019;11:E1077. [PMID: 31752284 DOI: 10.3390/v11111077] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
87 Marín-navarrete R, Magis-rodríguez C, Villalobos-gallegos L, Villafuerte-garcía A, Pérez-lópez A, Ruiz-herrera K, Sánchez-domínguez R, Ponce-ramos M, Morales-carcaño A, Bravo-garcía E, Uribe Zúñiga P, Medina-mora ME. Development of an evidence-based model of rapid testing, counseling and referral patients with HIV, HVC and other STDs in Mexican addiction treatment centers. Salud Ment 2019;42:191-201. [DOI: 10.17711/sm.0185-3325.2019.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
88 Malagnino V, Cerva C, Maffongelli G, Teti E, Foroghi Biland L, Cesta N, De Masi M, Stingone C, Armenia D, Svicher V, Salpini R, Andreoni M, Sarmati L. HBcAb seropositivity is correlated with poor HIV viremia control in an Italian cohort of HIV/HBV-coinfected patients on first-line therapy. Sci Rep 2019;9:11942. [PMID: 31420570 DOI: 10.1038/s41598-019-46976-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
89 Anabire NG, Tetteh WJ, Obiri-Yaboah D, Annan I, Luuse AT, Aryee PA, Helegbe GK, Hagan OCK, Eliason S. Evaluation of hepatic and kidney dysfunction among newly diagnosed HIV patients with viral hepatitis infection in Cape Coast, Ghana. BMC Res Notes 2019;12:466. [PMID: 31366401 DOI: 10.1186/s13104-019-4513-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
90 Kapoor N, Audsley J, Rupali P, Sasadeusz J, Paul TV, Thomas N, Lewin SR. A gathering storm: HIV infection and nonalcoholic fatty liver disease in low and middle-income countries. AIDS 2019;33:1105-15. [PMID: 31045941 DOI: 10.1097/QAD.0000000000002161] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
91 Choy CY, Ang LW, Ng OT, Leo YS, Wong CS. Factors Associated with Hepatitis B and C Co-Infection among HIV-Infected Patients in Singapore, 2006-2017. Trop Med Infect Dis 2019;4:E87. [PMID: 31137801 DOI: 10.3390/tropicalmed4020087] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
92 Kim AY. Hepatitis B Virus and HIV Coinfection: Fibrosis, Fat, and Future Directions. Am J Gastroenterol 2019;114:710-2. [PMID: 30985299 DOI: 10.14309/ajg.0000000000000231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
93 Gantner P, Cotte L, Allavena C, Bani-Sadr F, Huleux T, Duvivier C, Valantin MA, Jacomet C, Joly V, Chéret A, Pugliese P, Delobel P, Cabié A, Rey D; Dat’AIDS Study Group. Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection. PLoS One 2019;14:e0215464. [PMID: 30998789 DOI: 10.1371/journal.pone.0215464] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
94 Wooten D, Karris MY. The As and Bs of HIV and Hepatitis Co-Infection. Trop Med Infect Dis 2019;4:E55. [PMID: 30934708 DOI: 10.3390/tropicalmed4020055] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
95 Shata MTM, Abdel-Hameed EA, Rouster SD, Yu L, Liang M, Song E, Esser MT, Shire N, Sherman KE. HBV and HIV/HBV Infected Patients Have Distinct Immune Exhaustion and Apoptotic Serum Biomarker Profiles. Pathog Immun 2019;4:39-65. [PMID: 30815625 DOI: 10.20411/pai.v4i1.267] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
96 Ganesan M, Poluektova LY, Kharbanda KK, Osna NA. Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression. World J Gastroenterol 2019; 25(4): 398-410 [PMID: 30700937 DOI: 10.3748/wjg.v25.i4.398] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 9.0] [Reference Citation Analysis]
97 Adesina E, Oyero O, Okorie N, Amodu L, Omojola O, Adeyeye B. Information Use and Knowledge of HIV/Hepatitis B Co-Infection in Lagos, Nigeria. Health 2019;11:671-682. [DOI: 10.4236/health.2019.116056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
98 Bivigou-mboumba B. Human Immunodeficiency Virus-Hepatitis B Virus (HIV-HBV) Coinfection. Advances in HIV and AIDS Control 2018. [DOI: 10.5772/intechopen.78567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
99 Zhang S, Wang F, Zhang Z. Current advances in the elimination of hepatitis B in China by 2030. Front Med. 2017;11:490-501. [PMID: 29170919 DOI: 10.1007/s11684-017-0598-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]